NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund

INVEST VIA NRE/NRO

Mahindra Manulife Business Cycle Fund Growth for NRI [14.29]

Min Investment

1,000

Fund Size

1,199.71 Cr

Expense Ratio

2.1%

Exit Load

1%

SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671

14.29

0.14%

NAV as on 17 Nov 24, 12:00 AM

very high risk

equity other

equity

NAV as on 17 Nov 24, 12:00 AM

very high risk

equity other

equity

42.20%p.a.

Last 1Y

0.00%p.a.

Last 3Y

0.00%p.a.

Last 5Y

42.03%p.a.

Since Inception

About Mahindra Manulife Business Cycle Fund Growth for NRIs

NRIs can achieve long-term capital appreciation by investing in the Mahindra Manulife Business Cycle Fund Growth scheme from Mahindra Manulife Investment Management Pvt. Ltd.. It is a Equity - Other mutual fund scheme that predominantly invests in Equity - Other stocks of companies. Launched on Sep 2023, Mahindra Manulife Business Cycle Fund Growth is Equity - Other fund of its category with 1,199.71 Cr fund under management as on Nov 2024. The expense ratio of this fund is less than that of most other Fund category Equity - Other funds.

  • Mahindra Manulife Business Cycle Fund Growth delivered 42.2% annual returns during the last year. It has delivered 42.0% average annual returns since the fund was launched.
  • Mahindra Manulife Business Cycle Fund Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
  • The scheme has predominantly invested in equity

Fund Objective

The Scheme shall seek to generate long term capital appreciation by investing predominantly in equity and equity related securities with a focus on identifying and investing in business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy. However, there is no assurance that the objective of the Scheme will be realized.

Top 10 Holdings

HDFC Bank Ltd

6.93%

Reliance Industries Ltd

4.05%

State Bank of India

3.73%

Infosys Ltd

3.64%

ITC Ltd

2.52%

Hindustan Unilever Ltd

2.52%

IndusInd Bank Ltd

2.40%

Indus Towers Ltd Ordinary Shares

2.36%

Divi's Laboratories Ltd

2.27%

NTPC Ltd

2.18%

Fund Managers

  1. Krishna Sanghavi (Sep 2023 - Present)
  2. Renjith Radhakrishnan (Sep 2023 - Present)
  3. Pranav Patel (Jan 2024 - Present)

Key Information

View Scheme Document

Mahindra Manulife Business Cycle Fund Growth SIP Calculator

If invested

5,000

per month

For a period of

Investment of 0 could have been

0(+0.0%)

0 (+0.0%)

This Fund

0 (+0.0%)

Fixed Deposit

NRI Mutual Fund Tax on Mahindra Manulife Business Cycle Fund Growth

Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.

Fund TypeShort-term Capital Gains (STCG) TaxLong-term Capital Gains (LTCG) Tax
Equity mutual funds15%10% (above Rs. 1 lakh LTCG) without indexation*
Debt & other types of fundsAt tax slab rate20% with indexation benefits

How can NRIs invest in Mahindra Manulife Business Cycle Fund Growth?

NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:

  • Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
  • PAN Number
  • Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
  • Passport – front and back
  • Passport size photograph
  • signature

If all details are correct, your KYC will be approved within 7 to 8 business days.

  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in Mahindra Manulife Business Cycle Fund Growth
  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
  • City and country of birth
  • NRE/NRO bank account statement/ canceled cheque for the latest 3 months
  • Nominee details

Frequently Asked Questions